Skip to content

Bo Kara

VP Process Development

Bo has over 30 years’ experience in the biotechnology industry. He has expertise in the development of CMC for a wide range of protein, viral vector and cell therapy medicinal products. His deep knowledge of the technical, regulatory and commercial issues faced at each stage of process and product development has led to the progression of multiple assets from preclinical development through to commercial launch. Prior to joining Evox Therapeutics, Bo was Head Process Development, Cell Gene Therapy at GSK, Head R&D at Fujifilm and Head Process Development at AZ and holds an MSc in Biochemistry and Biotechnology.

Bo Kara

We use cookies to give you the best experience of using this website. By continuing to use this site, you accept our use of cookies. Please read our Cookie Policy for more information.